MétaCan
Menu
Back to cohort

PF316 THE CLINICAL CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH AGGRESSIVE LARGE CELL LYMPHOMA AND DIABETES MELLITUS

2019· article· en· W2953212652 on OpenAlexaff
Oren Pasvolsky, Amit Akirov, Brenda Elias, Pia Raanani, Ronit Gurion, Uri Rozovski

Bibliographic record

VenueHemaSphere · 2019
Typearticle
Languageen
FieldMedicine
TopicChronic Lymphocytic Leukemia Research
Canadian institutionsPrincess Margaret Cancer Centre
Fundersnot available
KeywordsMedicineLymphomaInternal medicineSingle CenterRetrospective cohort studyDiabetes mellitusAggressive lymphomaEpidemiologyMedical recordGastroenterologyRituximab

Abstract

fetched live from OpenAlex

Background: Epidemiological studies suggest that patients with diabetes mellitus (DM) are at‐risk to develop several types of cancers, including non‐Hodgkin lymphoma. Whether DM affects the clinical presentation or outcome of patients with lymphoma is unknown. Since patients with DM are prone to develop infectious complications, we hypothesize that the co‐occurrence of DM would increase the rate and/or severity of infectious complications in patients with lymphoma who receive chemotherapy. Aims: To describe the clinical characteristics and outcomes of patients with DM who received treatment for aggressive large cell lymphoma. Methods: This is a single center retrospective single center study. We included all consecutive patients who were diagnosed with aggressive large cell lymphoma and were treated at our institute between 2013 and 2017. Demographics, disease‐related and outcome data were extracted from the electronic medical records. Additional data and lab results were extracted from the hospital database. Categorical variables were compared using the χ2 or the Fischer exact test, and Mann Whitney was used to compare medians. Results: Between the years 2013 and 2017 we treated 226 patients with aggressive large cell lymphoma, most (n = 219, 96%) with diffuse large B cell lymphoma. In this cohort 49 patients (22%) had type 2 DM. None of our patients had type 1 DM. The median age of patients with DM was 70 years, and of non‐DM patients 65 years (P = 0.001). Patients with DM tended to have higher baseline BMI values (P = 0.057), but were comparable in all other demographic characteristics. Likewise, response to therapy, relapse rates and survival outcomes were similar in patients with DM compared to non‐DM patients. There were 133 hospital admissions due to febrile neutropenia (FN) in the entire cohort. Patients with DM had higher rates of admissions due to FN (P = 0.004). The admission rate in patients with DM remained higher after age‐matched subgroup analysis (P = 0.005). Yet, the duration of hospitalizations and number of admissions to the ICU were similar in patients with or without DM. In patients with DM, improved glycemic control during FN hospitalizations was associated with shorter hospital duration (P = 0.007). However, Hemoglobin A1C levels were not associated with increased risk for FN or infectious complications. Summary/Conclusion: Patients with aggressive large cell lymphoma and DM have higher rates of hospitalizations due to FN. In this high risk population, perhaps more aggressive measures should be made to avoid infectious complications. Furthermore, our data suggests that improved glycemic control during hospitalization is associated with shorter length of hospitalization due to FN in patients with DM.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.027
Threshold uncertainty score0.328

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.010
GPT teacher head0.276
Teacher spread0.267 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueHemaSphereSame topicChronic Lymphocytic Leukemia ResearchFrench-language works237,207